How do we determine the utility of screening tools?

American Academy of Pediatrics, Council on Children With Disabilities, Section on Developmental and Behavioral Pediatrics, Bright Futures Steering Committee, & Medical Home Initiatives for Children With Special Needs Project Advisory Committee. (2006). Identifying infants and young children with developmental disorders in the medical home: An algorithm for developmental surveillance and screening [published correction appears in Pediatrics 2006; 119: 1808–1809]. Pediatrics, 118, 405–420.

American Cancer Society. (2018). https://www.cancer.org/healthy/find-cancer-early/cancer-screening-guidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer.html

Chlebowski C. Robins D. L. Barton M. L. Fein D. (2013). Large-scale use of the modified checklist for autism in low-risk toddlers. Pediatrics, 131(4), e1121–e1127.

Christensen D. L. Bilder D. A. Zahorodny W. Pettygrove S. Durkin M. S. Fitzgerald R. T. Rice C. . . . Yeargin-Allsopp M. (2015). Prevalence and characteristics of autism spectrum disorder among 4-year-old children in the Autism and Developmental Disabilities Monitoring Network. Journal of Developmental and Behavioral Pediatrics, 37, 1–8.

Christensen D. L. Van Naarden Braun K. Baio J. Bilder D. Charles J. Constantino J. N. . . . Yeargin-Allsopp M. (2016). Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012. MMWR Surveillance Summaries, 65(3), 1–24.

Food and Drug Administration. (n.d.). https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/HomeUseTests/ucm126067.htm

Guthrie W. Swineford L. B. Nottke C. Wetherby A. M. (2013). Early diagnosis of autism spectrum disorder: Stability and change in clinical diagnosis and symptom presentation. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 54(5), 582–590. https://doi.org/10.1111/jcpp.12008

Johnson C. P. Myers S. M. , & The Council on Children with Disabilities. (2007). Identification and evaluation of children with autism spectrum disorders. Pediatrics, 120(5), 1183–1215.

Ozonoff S. Young G. S. Landa R. J. Brian J. Bryson S. Charman T. . . . Iosif A. M. (2015). Diagnostic stability in young children at risk for autism spectrum disorder: A Baby Siblings Research Consortium study. Journal of Child Psychology and Psychiatry, 56(9), 988–998.

Rapin I. (1996). Neurological examination [In Rapin I. (Ed.), Preschool children with inadequate communication: Developmental language disabilities, autism, low IQ]. Clinics in Developmental Medicine, 139, 98–122.

Robins D. L. Casagrande K. Barton M. Chen C. M. A. Dumont-Mathieu T. Fein D. (2014). Validation of the Modified Checklist for Autism in Toddlers, Revised with Follow-up (M-CHAT-R/F). Pediatrics, 133(1), 37–45.

Siu A. L. Bibbins-Domingo K. Grossman D. C. Baumann L. C. Davidson K. W. Ebell M. . . . Pignone M. P. (2016). Screening for autism spectrum disorder in young children: US Preventive Services Task Force recommendation statement. Journal of the American Medical Association, 315(7), 691–696.

Stenberg N. Bresnahan M. Gunnes N. Hirtz D. Hornig M. Lie K. K. . . . Stoltenberg C. (2014). Identifying children with autism spectrum disorder at 18 months in a general population sample. Paediatric and Perinatal Epidemiology, 28, 255–262.

Sturner R. Howard B. Bergmann P. Morrel T. Andon L. Marks D. . . . Landa R. (2016). Autism screening with online decision support by primary care pediatricians aided by M-CHAT/F. Pediatrics, 138, Article e20153036.

Taylor D. Durigon M. Davis H. Archibald C. Konrad B. Coombs D. . . . Ogilvie G. (2015). Probability of a false-negative HIV antibody test result during the window period: A tool for pre- and post-test counselling. International Journal of STD and AIDS, 26(4), 215–225.

UK National Screening Committee (2012) UK NSC recommendation on autism screening in children. https://legacyscreening.phe.org.uk/autism